Evaluating the Effectiveness of Switching to Insulin Degludec from Other Basal Insulins in a Real-World Canadian Population with Type 1 or Type 2 Diabetes: The CAN-TREAT Study.
Stewart B HarrisOlubukola AjalaBasel BariJoanne LiutkusJina HahnOliver MartynDeborah ZwickerPublished in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2021)
ClinicalTrials.gov NCT03674866.